Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Lactoferricin but not lactoferrin inhibit herpes simplex virus type 2 infection in mice.
Shestakov A, Jenssen H, Nordström I, Eriksson K.
Antiviral Res. 2012 Mar;93(3):340-5. Epub 2012 Jan 16.
Related citations
Efficacy of ASP2151, a helicase-primase inhibitor, against thymidine kinase-deficient herpes simplex virus type 2 infection in vitro and in vivo.
Himaki T, Masui Y, Chono K, Daikoku T, Takemoto M, Haixia B, Okuda T, Suzuki H, Shiraki K.
Antiviral Res. 2012 Feb;93(2):301-4. Epub 2011 Dec 4.
Genotypic characterization of herpes simplex virus DNA polymerase UL42 processivity factor.
Burrel S, Aït-Arkoub Z, Agut H, Boutolleau D.
Antiviral Res. 2012 Jan;93(1):199-203. Epub 2011 Oct 28.
CpG and poly(I:C) stimulation of dendritic cells and fibroblasts limits herpes simplex virus type 1 infection in an IFNβ-dependent and -independent way.
Gaajetaan GR, Geelen TH, Grauls GE, Bruggeman CA, Stassen FR.
Antiviral Res. 2012 Jan;93(1):39-47. Epub 2011 Oct 25.
Antiherpetic activity of a sulfated polysaccharide from Agaricus brasiliensis mycelia.
Cardozo FT, Camelini CM, Mascarello A, Rossi MJ, Nunes RJ, Barardi CR, de Mendonça MM, Simões CM.
Antiviral Res. 2011 Oct;92(1):108-14. Epub 2011 Jul 20.
Antiherpes activity of glucoevatromonoside, a cardenolide isolated from a Brazilian cultivar of Digitalis lanata.
Bertol JW, Rigotto C, de Pádua RM, Kreis W, Barardi CR, Braga FC, Simões CM.
Antiviral Res. 2011 Oct;92(1):73-80. Epub 2011 Jul 7.
N-Methanocarbathymidine is more effective than acyclovir for treating neonatal herpes simplex virus infection in guinea pigs.
Bernstein DI, Bravo FJ, Clark JR, Earwood JD, Rahman A, Glazer R, Cardin RD.
Antiviral Res. 2011 Nov;92(2):386-8. Epub 2011 Sep 7.
CK2 inhibitors increase the sensitivity of HSV-1 to interferon-β.
Smith MC, Bayless AM, Goddard ET, Davido DJ.
Antiviral Res. 2011 Sep;91(3):259-66. Epub 2011 Jun 22.
Virostatic potential of micro-nano filopodia-like ZnO structures against herpes simplex virus-1.
Mishra YK, Adelung R, Röhl C, Shukla D, Spors F, Tiwari V.
Antiviral Res. 2011 Nov;92(2):305-12. Epub 2011 Aug 26.
Topical cream-based oxyresveratrol in the treatment of cutaneous HSV-1 infection in mice.
Lipipun V, Sasivimolphan P, Yoshida Y, Daikoku T, Sritularak B, Ritthidej G, Likhitwitayawuid K, Pramyothin P, Hattori M, Shiraki K.
Antiviral Res. 2011 Aug;91(2):154-60. Epub 2011 Jun 2.
Expression of herpes simplex virus type 1 recombinant thymidine kinase and its application to a rapid antiviral sensitivity assay.
Shiota T, Lixin W, Takayama-Ito M, Iizuka I, Ogata M, Tsuji M, Nishimura H, Taniguchi S, Morikawa S, Kurane I, Mizuguchi M, Saijo M.
Antiviral Res. 2011 Aug;91(2):142-9. Epub 2011 Jun 2.
Three-dimensional analysis of combination effect of ellagitannins and acyclovir on herpes simplex virus types 1 and 2.
Vilhelmova N, Jacquet R, Quideau S, Stoyanova A, Galabov AS.
Antiviral Res. 2011 Feb;89(2):174-81. Epub 2010 Dec 4.
Oligomeric proanthocyanidins from Rumex acetosa L. inhibit the attachment of herpes simplex virus type-1.
Gescher K, Hensel A, Hafezi W, Derksen A, Kühn J.
Antiviral Res. 2011 Jan;89(1):9-18. Epub 2010 Nov 9.
Effects of therapy using a helicase-primase inhibitor (HPI) in mice infected with deliberate mixtures of wild-type HSV-1 and an HPI-resistant UL5 mutant.
Sukla S, Biswas S, Birkmann A, Lischka P, Ruebsamen-Schaeff H, Zimmermann H, Field HJ.
Antiviral Res. 2010 Jul;87(1):67-73. Epub 2010 Apr 24.
Phenotypic and genotypic characterization of acyclovir-resistant clinical isolates of herpes simplex virus.
Sauerbrei A, Deinhardt S, Zell R, Wutzler P.
Antiviral Res. 2010 Jun;86(3):246-52. Epub 2010 Mar 6.
A highly lipophilic sulfated tetrasaccharide glycoside related to muparfostat (PI-88) exhibits virucidal activity against herpes simplex virus.
Ekblad M, Adamiak B, Bergstrom T, Johnstone KD, Karoli T, Liu L, Ferro V, Trybala E.
Antiviral Res. 2010 May;86(2):196-203. Epub 2010 Feb 20.
Recurrent vaginal shedding of herpes simplex type 2 virus in the mouse and effects of antiviral therapy.
Farley N, Bernstein DI, Bravo FJ, Earwood J, Sawtell N, Cardin RD.
Antiviral Res. 2010 May;86(2):188-95. Epub 2010 Feb 16.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on